HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Leukemia

Leukemia

Leukemia, a form of cancer affecting the blood and bone marrow, remains a significant focus of cancer research due to its complex nature and diverse subtypes. Scientists delve into understanding the genetic mutations and abnormal cell growth underlying leukemia, aiming to develop targeted therapies that minimize side effects and improve outcomes. Advances in precision medicine allow for tailored treatments based on individual genetic profiles, offering hope for more effective and personalized care. Immunotherapy, harnessing the body's immune system to target cancer cells, shows promise in leukemia treatment, with ongoing studies exploring its potential. Additionally, research into novel drug combinations and stem cell transplant techniques continues to push the boundaries of leukemia treatment, striving for better survival rates and quality of life for patients.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp